سرمایه گذاری دارویی تامین
تیپیکو | Stocks - Tehran Stock Exchange (TSE)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 32,870 1.23
Close Price: 33,370
Financial Ratios
AGM
Interim
2026/09/08 Fiscal Year 2026/05/2112 Month | 2026/09/01 Fiscal Year 2026/05/2112 Month | 2026/08/25 Fiscal Year 2026/05/2112 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 96.33 | - | - | |
Gross Profit to Sales | 96.34 | - | - | |
Operating Margin | 97.72 | - | - | |
Gross Profit to Sales | 100 | - | - | |
Net Profit to Gross Profit | 96.33 | - | - | |
Return on Assets (ROA) | 42.37 | - | - | |
Return on Capital (%) | 210.23 | - | - | |
Return on Equity (ROE) | 66.82 | - | - | |
Working Capital Return | 83.75 | - | - | |
Fixed Asset Return | 23,715.08 | - | - | |
Loan Benefit Assessment | 1.58 | - | - | |
Current Ratio | 2.39 | 2.39 | 2.39 | |
Quick Ratio | 2.39 | 2.39 | 2.39 | |
Liquidity Ratio | 0.01 | 0.01 | 0.01 | |
Net Working Capital | 80,327,125 | 80,327,125 | 80,327,125 | |
Current Assets Ratio | 0.87 | 0.87 | 0.87 | |
Receivables Collection Period | 719.44 | - | - | |
Inventory to Working Capital | 0 | 0 | 0 | |
Working Capital Turnover | 0.87 | - | - | |
Fixed Asset Turnover | 246.18 | - | - | |
Total Asset Turnover | 0.44 | - | - | |
Debt Ratio | 0.37 | 0.37 | 0.37 | |
Debt to Equity | 0.58 | 0.58 | 0.58 | |
Long-Term Debt to Equity | 0 | 0 | 0 | |
Current Debt to Equity | 0.57 | 0.57 | 0.57 | |
Equity Ratio | 63.4 | 63.4 | 63.4 | |
Debt Coverage Ratio | 1.11 | 1.11 | 1.11 |